Endothelial Dysfunction and Cardiovascular Disease in Chronic Kidney Disease and Dialysis: A 2022 Update
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: closed (18 November 2022) | Viewed by 20120
Special Issue Editors
Interests: chronic kidney disease; cardiovascular disease; vascular calcification; diabetes mellitus; hemodialysis; peritoneal dialysis
Special Issues, Collections and Topics in MDPI journals
Interests: chronic kidney disease; kidney transplant; cardiovascular disease; oxidative stress
Special Issues, Collections and Topics in MDPI journals
Interests: oxidative stress; vascular calficiation and cardiovascular disease in diabetics; chronic kidney disease and hemodialysis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Patients with chronic kidney disease (CKD) carry a heavy cardiovascular burden and are prone to development and progression of atherosclerosis. Accounting for more than 11% of the general population, CKD is now considered a major health priority worldwide. Endothelial dysfunction, the hallmark of atherosclerosis, is evident even at early stages of the CKD, progresses along with deterioration of renal function, and is further accelerated in end-stage kidney disease (ESKD), partially by dialysis modalities. Therefore, understanding the molecular mechanisms underlying the onset of endothelial dysfunction and the identification of novel risk markers for cardiovascular disease in these patients is critical. In this Special Issue, we invite researchers to submit original research and review articles that will help to elucidate the interplay between endothelial dysfunction, vascular calcification, and cardiovascular disease in patients with CKD, kidney transplant recipients, and ESKD patients undergoing hemodialysis or peritoneal dialysis.
Dr. Vassilios Liakopoulos
Dr. Evangelia Dounousi
Dr. Stefanos Roumeliotis
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiovascular disease
- chronic kidney disease
- dialysis
- endothelial dysfunction
- hemodialysis
- peritoneal dialysis
- vascular calcification